Health Times of Rhode Island: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Times of Rhode Island.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on March 17, 2026

Mar. 17, 2026

US News & World Reports: UOI’s East Bay Surgery Center Among Nation’s Best ASCs for Orthopedics & Spine

EIN Presswire

Mar. 17, 2026

Coventry Structured Investments Supports Centurion Foundation's Acquisition of Two Rhode Island Hospitals

EIN Presswire

Mar. 17, 2026

NatureGlyco Blood Support Claims Evaluated: The Proven Glyco Care Formula for Healthy Blood Sugar Support

GlobeNewswire

Mar. 17, 2026

Mesoblast to Host R&D Day on April 8, 2026

GlobeNewswire

Mar. 17, 2026

DentaBiome Claims Evaluated: 2026 Oral Postbiotic Consumer Warning Report Issued

GlobeNewswire

Mar. 17, 2026

MEDVi GLP-1 Weight Loss Claims Evaluated: 2026 Report Examining "Most Trusted Online Medical Care" Positioning, Telehealth Structure, and Regulatory Context

GlobeNewswire

Mar. 17, 2026

Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting

GlobeNewswire

Mar. 17, 2026

Acrivon Therapeutics to Present Pre-Clinical AP3 Data at the 2026 AACR Annual Meeting Revealing Strong Synergy of ACR-368 with ADC Topo 1 Inhibitor Payloads and of both ACR-368 and ACR-2316 with Immune Checkpoint Inhibitors

GlobeNewswire

Mar. 17, 2026

Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting

GlobeNewswire

Mar. 17, 2026

ORIC® Pharmaceuticals Announces Preclinical Rinzimetostat (ORIC-944) Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting

GlobeNewswire

Mar. 17, 2026

Galapagos Receives Transparency Notification from Bank of America

GlobeNewswire

Mar. 17, 2026

Galapagos ontvangt transparantieverklaring van Bank of America

GlobeNewswire

Mar. 17, 2026

Silexion Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire

Mar. 17, 2026

ArriVent to Present Two Preclinical Posters on the EGFR Inhibitor Firmonertinib and on the Novel dual-target MUC16/NaPi2b Tetravalent ADC ARR-002 at the 2026 AACR Annual Meeting

GlobeNewswire

Mar. 17, 2026

OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital

GlobeNewswire

Mar. 17, 2026

Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026

GlobeNewswire

Mar. 17, 2026

Caring for the Body, PLLC Launches Physician-Led Re-Think Aging Platform to Advance a New Era of Cognitive Decline Prevention and Longevity Care

GlobeNewswire

Mar. 17, 2026

Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting

GlobeNewswire

Mar. 17, 2026

Adagene’s Muzastotug (ADG126) to be Highlighted in Two Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA

GlobeNewswire

Mar. 17, 2026

Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial

GlobeNewswire